Smoke studies were not performed under dynamic conditions.
Inspection Record
Greenwich Rx — FDA 483 Findings
Inspectors Camerson E MooreThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Personnel infrequently changed and sanitized gloves to prevent contamination.
Compounding with components, containers or other materials that have not been verified to assure that they do not contribute endotoxin contamination that may be objectionable given the product's intended use.
Failure to conduct media fills that closely simulate aseptic production operations under the worst-case, most-challenging, and stressful conditions.
The facility design was observed to allow the influx of lesser quality air into a classified area containing higher quality air.
Personnel donned gowning apparel improperly, in a way that may have caused the gowning apparel to become contaminated.
Your firm produced drugs while construction was underway in an adjacent area without adequate controls to prevent contamination of the production environment and product.
Personnel were observed moving quickly in a critical area or in an area immediately adjacent to a critical area likely causing disrnption ofunidirectional airflow.
Microbial contamination was present in the ISO 5 area and areas adjacent to production areas.
Personnel were observed conducting aseptic manipulations where the movement of "first air" in the ISO 5 area is blocked or disrupted.
Inadequate <Redacted B4> testing on <Redacted B4> used to sterilize drug products.
Use of ingredients not intended for pharmaceutical use in sterile drug production.
A pattern of frequent or acute pressure reversals was observed from areas of less clean air to areas of higher air cleanliness.
Lack of disinfection of supplies at each transition from areas of lower quality air to areas of higher quality air.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- La Vita Compounding Pharmacy, LLC2018-07-09 · US FDASimilar to finding 7 Your firm produced drugs while construction was underway in an adjacent area without adequate controls to prevent contamination of the production environment…
- Carolina Infusion LLC2026-08-18 · US FDASimilar to finding 10 Personnel were observed conducting aseptic manipulations where the movement of "first air" in the ISO 5 area is blocked or disrupted.
- VA New Jersey Health Care System2020-02-27 · US FDASimilar to finding 7 Your firm produced drugs while construction was underway in an adjacent area without adequate controls to prevent contamination of the production environment…
- Avenue Pharmacy Inc. dba Pathway Pharmacy2019-12-06 · US FDASimilar to finding 7 Your firm produced drugs while construction is underway in an adjacent area without adequate controls to prevent contamination of the production environment…
- Houston Rx LLC2026-08-28 · US FDASimilar to finding 13 A pattern of frequent or acute pressure reversals was observed from areas of less clean air to areas of higher air cleanliness.
A record as of the US FDA document published on 2026-10-21. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.